Bioptimus
FranceWho owns Bioptimus?
Bioptimus is a French Biotech company, currently owned by Bpifrance Investissement since 2025 and 6 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Co-held by Sofinnova Partners, FRST Capital, Bpifrance Investissement, Felix Capital, Hitachi Ventures, Cathay Capital and Andera Partners since 2024.
- ·7 distinct PE sponsors across ownership cycles.
Ownership history
7 ownership periods · co-invest detected
More from BioDiscovery 7
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Bioptimus?
Bioptimus is currently owned by Bpifrance Investissement, Felix Capital and 5 others, through BioDiscovery 7, since 2025.
When did Bpifrance Investissement and 6 others acquire Bioptimus?
Bpifrance Investissement and 6 others acquired Bioptimus in 2025.
Who has owned Bioptimus over time?
Bioptimus has been through 7 private-equity ownership periods: Sofinnova Partners · via Sofinnova Digital Medicine I · since 2024; FRST Capital · via Frst 3 · since 2024; Bpifrance Investissement · via Large Venture · since 2025; Felix Capital · via Felix Capital Fund IV · since 2025; Hitachi Ventures · via Hitachi Ventures Fund III · since 2025; Cathay Capital · via Cathay Innovation Fund III · since 2025; Andera Partners · via BioDiscovery 7 · since 2025.